Navigation Links
InnovationRx, a Prescription Adherence Solutions Company, and InforMedix Partner to Market and Sell End-to-End Medication Adherence Solutions
Date:4/17/2008

mes, and sponsor return-on-investment for each level of non-adherence risk. It is estimated that medication non-adherence, defined as the failure of patients to take medications as prescribed, results in $300 billion of annual costs to the U.S. healthcare system, $100 billion of which is hospital costs. In addition, it is estimated that non-adherence causes 40% of nursing home admissions, and is responsible for between 10% and 28% of all hospital admissions.

Sean Teare, President of InnovationRx stated, "We are thrilled to be working with InforMedix to uniquely combine our proprietary assessment and behavioral modification techniques and technologies, anchored in pharmacist-based call centers, with InforMedix's real-time prompting, monitoring, reporting, and automatic outbound alerting when patients miss their medications, or their health status is declining. Med-eXpert's detailed Web-enabled reports for each patient, graphically depicting their reasons for non-adherence (e.g. side effects, ran out of medications, change in doctors' orders, etc.), will enhance the consulting effectiveness of our pharmacists.

Bruce A. Kehr, M.D., chairman and Chief Executive Officer of InforMedix commented "What is really exciting about our plans with InnovationRx is that through combining their products and services with our own, we offer the marketplace an end-to-end solution that first assesses risk of patient non-adherence, and then assigns that patient exactly what products and services they need to optimize adherence and health. The addition of risk assessment algorithms, and pharmacist-based call centers receiving real-time adherence and health status data from our Med-eXpert database, from patients using our Med-ePhone or Med-eMonitor, powerfully completes a comprehensive medication adherence solution that is unique to the marketplace. We believe that by working together with InnovationRx, backed by the global reach of their parent, Innovation Group, we can sign
'/>"/>

SOURCE InforMedix Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Signalife Receives FDA Clearance for OTC Non-Prescription Event Recorder Device
2. Caliper Life Sciences Forms Alliance With Horizon Discovery to Provide Enhanced Solutions for Cancer Research Based on Isogenic Cell Lines
3. Compressus Completes Interoperability Implementation for E-Rad Solutions Teleradiology Customers
4. Abt Associates Clinical Trials Announces Name Change to Abt Bio-Pharma Solutions, Inc.
5. HighPoint Solutions Selected by Global Biotechnology Company to Provide Master Data Management Solution
6. Finesse Solutions Opens New E-Store for Sensors
7. Environmental Operating Solutions Completes Initial Tranche of $2.5 Million Institutional Financing
8. Immucor To Acquire BioArray Solutions Ltd.
9. The Bill & Melinda Gates Foundation, BIO, and Bio Ventures for Global Health Invite Proteome Systems CEO to Speak on TB Diagnostics Solutions At Partnering for Global Health Forum, Washington D.C.
10. Finesse Solutions, LLC Announces OPC Connectivity With Nova BioProfile 400
11. Hybrid materials: Exciting interdisciplinary field offering future solutions for industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 21, 2013 According to a ... http://www.transparencymarketresearch.com ) "Biochip Products and Services Market (Microarrays, Reagents, ... Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," the market ... is expected to grow at a CAGR of 10.1% ... of USD 4.7 billion in 2018. Browse ...
(Date:5/21/2013)... 2013  Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer ... infectious diseases, announced today that Jeffrey Riley ... Marcum LLP MicroCap Conference on Thursday, May 30, 2013 in ... Hyatt Hotel. Mr. Riley is scheduled to present at 10:00 ... Biologics, presentation can be accessed by logging onto the web ...
(Date:5/21/2013)... May 21, 2013 Inflamax scientists ... the ITN to design the study, which will ... key clinical models used in the study of ... Nasal Allergen Challenge (NAC) models. Although both the ... publications, to date no direct comparison between the ...
(Date:5/21/2013)... Lake, MN (PRWEB) May 21, 2013 The ... trade show display solution for sales and marketing teams looking ... Displays describes the kit as “everything you’ll need to ... Fusion Fabric Display Kit comes with a number of displays ... all-around trade booth 20 feet by 20 feet in size. ...
Breaking Biology Technology:The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5Synthetic Biologics to Present at the 2nd Annual Marcum LLP MicroCap Conference 2Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation. 2GLM Displays Announces All-in-One Formulate Fusion Fabric Display Kit 2
... - EastMed Inc., the medical manufacturing company that caters ... clearance to market its flagship product, uresta(TM) Continence Care, ... to get the official word from the FDA," said ... (TM) Continence Care offers an innovative and cost-effective option ...
... Nov. 25 /PRNewswire/ - Aegera Therapeutics Inc. today announced ... the XIAP antisense oligonucleotide, AEG35156, will be highlighted in ... the American Society of Hematology (ASH) in San Francisco, ... presentation is entitled "Phase I/II Trial of the XIAP ...
... a business unit of DSM Pharmaceutical Products, and Dutch,biotechnology company ... today announced that Hungary-based Gedeon Richter Plc. signed a,commercial license ... the PER.C6(R) platform. , ... About PER.C6(R) technology , ...
Cached Biology Technology:Aegera Therapeutics' phase 1/2 clinical trial results selected for oral presentation at 2008 ASH Annual Meeting 2Aegera Therapeutics' phase 1/2 clinical trial results selected for oral presentation at 2008 ASH Annual Meeting 3DSM Biologics and Crucell Announce Commercial PER.C6(R) Licensing Agreement with Gedeon Richter 2DSM Biologics and Crucell Announce Commercial PER.C6(R) Licensing Agreement with Gedeon Richter 3DSM Biologics and Crucell Announce Commercial PER.C6(R) Licensing Agreement with Gedeon Richter 4
(Date:5/21/2013)... largest scientific society, invites news media coverage of ... 2013, in Indianapolis, Ind. It will take place ... hotels. , With more than 7,100 presentations on ... astronomy to zoology ― the meeting will offer ... of spot news and feature possibilities. The topics ...
(Date:5/21/2013)... which alter the way genes function without changing ... in the blood of pregnant women during any ... depression in the weeks after giving birth, and ... , The findings of the small study involving ... journal Molecular Psychiatry . , "Postpartum depression ...
(Date:5/20/2013)... suggests that a compound abundant in the Mediterranean diet ... , By altering a very specific step in gene ... cells that die as scheduled. , One way that ... would cause them to die on a regular cycle ... cells, led by Ohio State University researchers, found that ...
Breaking Biology News(10 mins):Genetic predictors of postpartum depression uncovered by Hopkins researchers 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 3The compound in the Mediterranean diet that makes cancer cells 'mortal' 2The compound in the Mediterranean diet that makes cancer cells 'mortal' 3
... -- Strong evidence developed at Harvard School of Public ... an important contributor to the epidemic rise of obesity ... with these growing public health threats, experts from the ... schools, worksites and homes must take action to help ...
... may explain their ability to respond to regulatory inputs ... series of companion articles from the FANTOM4 consortium. This ... Central,s open access journals, including Genome Biology ... HCNE (highly conserved non-coding element) mediated long-range gene regulation ...
... Virginia Beach, a graduate student in Virginia Tech,s ... Rachel Carson Award for Scientific Excellence from the ... biologist at the agency,s White Sulphur Springs National ... who demonstrate superior scientific involvement and application to ...
Cached Biology News:Nutrition experts propose new class of low-sugar drinks to help stem obesity and diabetes epidemics 2Nutrition experts propose new class of low-sugar drinks to help stem obesity and diabetes epidemics 3FANTOM findings boost for biologists 2
... II RNase H- Reverse Transcriptase (RT) is ... H- RT. It is a DNA polymerase ... single-stranded RNA DNA or an RNA:DNA hybrid. ... introduction of point mutations rather than a ...
... (PNK) catalyzes the transfer of the ... of single- and double-stranded DNA, RNA, ... removes the 3'-phosphate from 3'-phosphoryl polynucleotides, ... to form a 3'-hydroxyl group. Storage ...
MOUSE ANTI GTP BINDING PROTEIN...
We offer solid and solution phase peptide synthesis including a whole range of modifications. Please send the details of your peptide synthesis need to info@rpeptide.com...
Biology Products: